nt.WebsitePharmaceuticalsFDA Safety Changes: Azithromycin Linked With Fatal Irregular Heart Rhythms CME/CE This article is intended for primary care clinicians, cardiologists, infectious disease specialists, pharmacists and other specialists who care for patients treated with azithromycin who may be at risk for potentially fatal heart arrhythmias.WebsitePharmaceuticalsSecondary Prevention in Acute